Literature DB >> 2311294

The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low serum concentrations.

M Super1, R J Levinsky, M W Turner.   

Abstract

When sera diluted to 5% in a buffer containing calcium and magnesium were incubated with mannan-coated ELISA plates, C4 fragments, properdin and factor B were bound to the plates as well as the expected opsonic C3 fragments, C3b and C3bi. The calcium-dependent lectin mannan-binding protein, which is structurally similar to C1q, was also shown to bind in this assay and analysis of sera from 179 healthy blood donors revealed that the binding levels of all these proteins were highly significantly correlated. Results obtained with a previously described C3b opsonic assay using zymosan also correlated with the mannan-binding levels. When the sera were diluted to 5% in the presence of Mg-EGTA there was no detectable binding of complement proteins to the mannan surface, confirming that no alternative pathway activation occurred at this serum concentration. When sera were diluted to 5% in a buffer containing EDTA in order to study immunoglobulin binding in the absence of complement activation, the levels of bound IgG1, IgG2, IgG3, IgA and IgM antibodies were found to be completely unrelated to the C3bi binding levels previously observed. The results suggest that in this experimental system using low concentrations of serum, mannan-binding protein initiates an antibody-independent mechanism of cleavage of the classical pathway component C4, which subsequently regulates the degree of cleavage of C3 and recruitment of alternative pathway proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2311294      PMCID: PMC1534755          DOI: 10.1111/j.1365-2249.1990.tb05170.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

Review 1.  CELL WALL OF YEASTS.

Authors:  H J PHAFF
Journal:  Annu Rev Microbiol       Date:  1963       Impact factor: 15.500

2.  A rapid objective method for measuring the yeast opsonisation activity of serum.

Authors:  R J Levinsky; B A Harvey; S Paleja
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

3.  The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.

Authors:  R G DiScipio
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

4.  Polymorphonuclear neutrophil iodination response as an estimate of defective yeast opsonization.

Authors:  D M Roberton; N K Dhanjal; R J Levinsky; J F Mowbray; M W Turner
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

5.  The use of avidin-biotin interaction in immunoenzymatic techniques.

Authors:  J L Guesdon; T Ternynck; S Avrameas
Journal:  J Histochem Cytochem       Date:  1979-08       Impact factor: 2.479

6.  Yeast opsonization in newborn infants and its relationship to parental atopy.

Authors:  V F Richardson; V F Larcher; J F Price
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

7.  A common congenital immunodeficiency predisposing to infection and atopy in infancy.

Authors:  V F Richardson; V F Larcher; J F Price
Journal:  Arch Dis Child       Date:  1983-10       Impact factor: 3.791

8.  The glucan components of the cell wall of baker's yeast (Saccharomyces cerevisiae) considered in relation to its ultrastructure.

Authors:  J S Bacon; V C Farmer; D Jones; I F Taylor
Journal:  Biochem J       Date:  1969-09       Impact factor: 3.857

9.  The effect of C3 levels on yeast opsonization by normal and pathological sera: identification of a complement independent opsonin.

Authors:  M A Kerr; J S Falconer; A Bashey; J S Beck
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

10.  A study of C3b deposition on yeast surfaces by sera of known opsonic potential.

Authors:  M W Turner; J F Mowbray; D R Roberton
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

View more
  23 in total

1.  Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: mannan-binding proteindependent cell-mediated cytotoxicity.

Authors:  Y Ma; K Uemura; S Oka; Y Kozutsumi; N Kawasaki; T Kawasaki
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

2.  Human mannose-binding protein functions as an opsonin for influenza A viruses.

Authors:  K L Hartshorn; K Sastry; M R White; E M Anders; M Super; R A Ezekowitz; A I Tauber
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

3.  Mannose-binding lectin 2 (MBL2) gene polymorphism in asthma and atopy among adults.

Authors:  J Aittoniemi; H Soranummi; A T Rovio; M Hurme; T Pessi; M Nieminen; J Karjalainen
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

4.  Isolation, cloning and functional characterization of porcine mannose-binding lectin.

Authors:  A Agah; M C Montalto; K Young; G L Stahl
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

5.  Asymmetry adjacent to the collagen-like domain in rat liver mannose-binding protein.

Authors:  R Wallis; K Drickamer
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

6.  Complement activation after oxidative stress: role of the lectin complement pathway.

Authors:  C D Collard; A Väkevä; M A Morrissey; A Agah; S A Rollins; W R Reenstra; J A Buras; S Meri; G L Stahl
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

7.  Complement-dependent cytotoxic activity of serum mannan-binding protein towards mammalian cells with surface-exposed high-mannose type glycans.

Authors:  M Ohta; T Kawasaki
Journal:  Glycoconj J       Date:  1994-08       Impact factor: 2.916

8.  Binding of mannan-binding protein to various bacterial pathogens of meningitis.

Authors:  L C van Emmerik; E J Kuijper; C A Fijen; J Dankert; S Thiel
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

9.  Human serum mannose-binding lectin (MBL)-associated serine protease-1 (MASP-1): determination of levels in body fluids and identification of two forms in serum.

Authors:  I Terai; K Kobayashi; M Matsushita; T Fujita
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

Review 10.  Mammalian lectins in activation and clearance mechanisms involving the complement system.

Authors:  K B Reid; M W Turner
Journal:  Springer Semin Immunopathol       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.